# What do the people who think ivermectin is effective against COVID-19 believe is the reason health providers do not want to prescribe it?

**URL:** <https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674>\
**Category:** The Quarantine Zone\
**Tags:** covid-quarantine\
**Created:** [January 13, 2022, 2:04am UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674 "2022-01-13T02:04:06Z")\
**Posts on this page:** 14\
**Page:** 3

<div class="post-metadata">

**Author:** ![SunUp](https://avatars.discourse-cdn.com/v4/letter/s/ea5d25/32.png) [@SunUp](https://boards.straightdope.com/u/SunUp)\
**Post date:** [January 18, 2022, 5:57pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/41 "2022-01-18T17:57:33Z")

</div>

Good Lord. Do you spend more time in the clinic or the courtroom?

I’m hoping its the former, and you have good representation and a sane judiciary to handle the latter…

---

<div class="post-metadata">

**Author:** ![Qadgop\_the\_Mercotan](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/qadgop_the_mercotan/32/83_2.png) [@Qadgop\_the\_Mercotan](https://boards.straightdope.com/u/Qadgop_the_Mercotan)\
**Post date:** [January 18, 2022, 6:00pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/42 "2022-01-18T18:00:28Z")

</div>

I spend little time in court, I’ve not lost any cases. They tend to get thrown out early in the process, as so many of the claims are ludicrous.

Even so I’ve spent more time writing affidavits, being deposed, and appearing in a court (county, state, federal) than I ever planned to. But I get paid the same hourly rate whether I’m seeing patients, doing legal paperwork, or sitting in a courtroom.

---

<div class="post-metadata">

**Author:** ![SpacemanSpiff\_II](https://avatars.discourse-cdn.com/v4/letter/s/e19adc/32.png) [@SpacemanSpiff\_II](https://boards.straightdope.com/u/SpacemanSpiff_II)\
**Post date:** [January 18, 2022, 6:16pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/43 "2022-01-18T18:16:12Z")

</div>

> [@Horatius](#):
>
> It also ignores the fact that in most countries, you can patent a “new use for an old substance”. So, sure, ivermectin might already be known as an anti-parasitic medication, but if you can show it’s also effective as an anti-COVID medication, you could patent that new use.

How does that work? Suppose the drug is off patent and there are generic versions selling for a few dollars. Now the original company comes up with a new use and get a patent for a “new use for an old substance”. Are all the generic versions now banned? If not, in what form does the new patent apply? And which countries have this “new use for an old substance” patent?

Bottom line and as a practical matter, I am extremely skeptical as to whether either the slightly modified version approach or the new use patent approach are significant in cases like this, in terms of changing the cost/profit considerations of old vs new drugs for pharmacy companies.

---

<div class="post-metadata">

**Author:** ![Jackmannii](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/jackmannii/32/311_2.png) [@Jackmannii](https://boards.straightdope.com/u/Jackmannii)\
**Post date:** [January 18, 2022, 6:56pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/44 "2022-01-18T18:56:36Z")

</div>

> [@SpacemanSpiff\_II](#):
>
> Bottom line and as a practical matter, I am extremely skeptical as to whether either the slightly modified version approach or the new use patent approach are significant in cases like this, in terms of changing the cost/profit considerations of old vs new drugs for pharmacy companies.

The example of taxanes in cancer therapy may be what you’re referring to as a “modified version approach”.

Around 1992 a major advance in treating certain types of cancer came with the introduction of a compound isolated from the Pacific yew tree. Since it took an average of six 100-year-old Pacific yew trees (a slow-growing species) to treat one patient, this was not an environmentally sustainable model. A semi-synthetic process yielded Taxol in 1995, which used needles and twigs of a European yew tree, making it a renewable resource and for a time at least, patentable. Since then, while generic taxol is still in use, new derivatives have been patented and come into production. There have also been patents on cell-culture derived taxanes, eliminating the need to harvest from existing trees.

This is a sizable market in which ingenuity as well as profit motive have come into play.

It always has seemed odd to me that the woo crowd brags about the high percentage of pharmaceuticals that are derived from “natural” substances, while simultaneously complaining that no one will research natural drugs because they can’t be patented. 🤔

---

<div class="post-metadata">

**Author:** ![Horatius](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/horatius/32/3572_2.png) [@Horatius](https://boards.straightdope.com/u/Horatius)\
**Post date:** [January 18, 2022, 7:08pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/45 "2022-01-18T19:08:24Z")

</div>

> [@SpacemanSpiff\_II](#):
>
> How does that work? Suppose the drug is off patent and there are generic versions selling for a few dollars. Now the original company comes up with a new use and get a patent for a “new use for an old substance”. Are all the generic versions now banned? If not, in what form does the new patent apply? And which countries have this “new use for an old substance” patent?

New uses often involve new dosages, that often aren’t commercially available, so they often patent a pill, say, made with the new dosage, or combined with other ingredients. [See an example here](https://patents.google.com/patent/US7202229B1/en). The notion is, anyone producing the pills with a similar dosage is intending to infringe on the patented use.

Sure, a doctor could prescribe the original drug at its original dose, and it would be hard to prove that it was being done for the patented use, but lots of companies find it profitable to do this anyways. Most doctors want the best possible result for their patients, so won’t go this route without some major reason why, like the person ahs no or bad health insurance.

Generic aren’t banned, because they can still be used for the pre-existing uses. So long as the companies producing them don’t start getting into “wink wink nudge nudge” kind of hijinks, they’re okay to keep selling as they always did.

If you google “patent new use for old drug”, you can see there’s lots of sites out there discussing this, from pro- anti- and neutral perspectives.

---

<div class="post-metadata">

**Author:** ![Horatius](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/horatius/32/3572_2.png) [@Horatius](https://boards.straightdope.com/u/Horatius)\
**Post date:** [January 18, 2022, 7:10pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/46 "2022-01-18T19:10:36Z")

</div>

> [@SpacemanSpiff\_II](#):
>
> Bottom line and as a practical matter, I am extremely skeptical as to whether either the slightly modified version approach or the new use patent approach are significant in cases like this, in terms of changing the cost/profit considerations of old vs new drugs for pharmacy companies.

[Well, but…](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/)

> [@](#):
>
> Some of the world’s most successful drugs were actually discovered through repurposing efforts and are or were at least originally protected only by MOT patents. For example, minoxidil (marketed as Rogaine®[[2]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn2)) was first developed as a vasodilator, but it was repurposed to treat hair loss and generated over $700 million in sales for Upjohn by patent expiry in 1996[[3]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn3). Similarly, sildenafil (marketed as Viagra®[[4]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn4)) was originally developed to treat angina, but it was repurposed to treat erectile dysfunction. Viagra reached global sales over $2.05 billion in 2013.[[5]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn5) Atomoxetine[[6]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn6) (marketed as Strattera®) was originally indicated as a therapeutic for Parkinson’s disease, but it was repurposed to treat attention deficit hyperactivity disorder (ADHD), with sales reaching upwards of $855 million in 2016.[[7]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn7) Similarly, rituximab was primarily intended to treat different types of cancers, but it was repurposed to treat rheumatoid arthritis (marketed as Retuxan®[[8]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn8)) with sales topping $7 billion in 2014.[[9]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn9) A more recent example is dextromethorphan (marketed as Nuedexta®) by Avanir Pharmaceuticals for the treatment of pseudobulbar affect.[[10]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn10) Dextromethorphan is one of the two active ingredients in Nuedexta, and also happens to be one of the primary ingredients of the age old cough-suppressant Robitussin®. Nuedexta is protected by three MOT patents[[11]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn11) and has brought in hundreds of millions of dollars leading “Otsuka Holdings of Japan to purchase Avanir in 2014 for $3.5 billion.”[[12]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn12)

Hundreds of millions to billions of dollars suggests your skepticism is misplaced.

---

<div class="post-metadata">

**Author:** ![Horatius](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/horatius/32/3572_2.png) [@Horatius](https://boards.straightdope.com/u/Horatius)\
**Post date:** [January 18, 2022, 7:16pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/47 "2022-01-18T19:16:22Z")

</div>

> [@Jackmannii](#):
>
> A semi-synthetic process yielded Taxol in 1995, which used needles and twigs of a European yew tree, making it a renewable resource and for a time at least, patentable.

And this highlight another argument against the “they can’t patent natural remedies” claims. You can’t patent the substance as it exists in nature, but you can patent a version where the active ingredient has been isolated and purified into a commercially vendible product.

So, sure, you can still go out and chew some twigs and bark, but if you want something a bit more convenient, you can just buy the patented version. Most people in our society opt for he second option.

---

<div class="post-metadata">

**Author:** ![SpacemanSpiff\_II](https://avatars.discourse-cdn.com/v4/letter/s/e19adc/32.png) [@SpacemanSpiff\_II](https://boards.straightdope.com/u/SpacemanSpiff_II)\
**Post date:** [January 18, 2022, 7:27pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/48 "2022-01-18T19:27:24Z")

</div>

> [@Jackmannii](#):
>
> The example of taxanes in cancer therapy may be what you’re referring to as a “modified version approach”.

I wasn’t referring to anything. I was responding to someone else who made a claim, and his/her claim was general. More below.

> [@Horatius](#):
>
> New uses often involve new dosages, that often aren’t commercially available, so they often patent a pill, say, made with the new dosage, or combined with other ingredients. [See an example here](https://patents.google.com/patent/US7202229B1/en). The notion is, anyone producing the pills with a similar dosage is intending to infringe on the patented use.
> 
> Sure, a doctor could prescribe the original drug at its original dose, and it would be hard to prove that it was being done for the patented use, but lots of companies find it profitable to do this anyways. Most doctors want the best possible result for their patients, so won’t go this route without some major reason why, like the person ahs no or bad health insurance.
> 
> Generic aren’t banned, because they can still be used for the pre-existing uses. So long as the companies producing them don’t start getting into “wink wink nudge nudge” kind of hijinks, they’re okay to keep selling as they always did.

So bottom line is that the new formulation 1) requires some expense in new studies etc., and 2) is not going to get a monopoly on the market because of all the “wink wink nudge nudge” in people using the generic versions. So there’s a bunch of cost and still not nearly as much return as a new drug.

Your example is of a guy who patented a form of aspirin specifically geared to cardiovascular health. What do you think most doctors are telling their patients? To take this patented version, or to just take X daily dose of generic aspirin? I don’t have any hard data, but I can tell you I’ve known numerous people who’ve been advised by heart doctors to take generic aspirin and never heard of anyone taking this patented drug.

> [@Horatius](#):
>
> Hundreds of millions to billions of dollars suggests your skepticism is misplaced.

Do any of your examples involve drugs which were off patent at the time they were repurposed for other use? AFAICT, you’re talking about drugs which were in development form at the time of the repurposing or at least under patent at the time. This has nothing at all to do with the situation we’re discussing.

---

<div class="post-metadata">

**Author:** ![Horatius](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/horatius/32/3572_2.png) [@Horatius](https://boards.straightdope.com/u/Horatius)\
**Post date:** [January 18, 2022, 8:14pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/49 "2022-01-18T20:14:09Z")

</div>

> [@Horatius](#):
>
> Dextromethorphan is one of the two active ingredients in Nuedexta, and also happens to be one of the primary ingredients of the age old cough-suppressant Robitussin®. Nuedexta is protected by three MOT patents[[11]](https://www.jdsupra.com/legalnews/why-method-of-treatment-patents-for-92813/#_ftn11) and has brought in hundreds of millions of dollars

> [@SpacemanSpiff\_II](#):
>
> Do any of your examples involve drugs which were off patent at the time they were repurposed for other use?

See the last example quoted above. [Dextromethorphan has been around since the late 50s](https://en.wikipedia.org/wiki/Dextromethorphan#History), but still made hundreds of millions of dollars for the people who patented the new use.

---

<div class="post-metadata">

**Author:** ![SpacemanSpiff\_II](https://avatars.discourse-cdn.com/v4/letter/s/e19adc/32.png) [@SpacemanSpiff\_II](https://boards.straightdope.com/u/SpacemanSpiff_II)\
**Post date:** [January 18, 2022, 8:34pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/50 "2022-01-18T20:34:58Z")

</div>

> [@Horatius](#):
>
> See the last example quoted above. [Dextromethorphan has been around since the late 50s](https://en.wikipedia.org/wiki/Dextromethorphan#History), but still made hundreds of millions of dollars for the people who patented the new use.

OK.

But dextromethorphan is one of the two active ingredients of Nuedexta. Would dextromethorphan work on its own and the developers of Nuedexta tinkered with and enhanced the formula in order to get a patent - which is what you’re suggesting to be feasible - or is it only the combination of the two active ingredients which is effective? If someone took Robitussen for pseudobulbar affect, would it work, just not quite as well as Nuedexta?

---

<div class="post-metadata">

**Author:** ![Qadgop\_the\_Mercotan](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/qadgop_the_mercotan/32/83_2.png) [@Qadgop\_the\_Mercotan](https://boards.straightdope.com/u/Qadgop_the_Mercotan)\
**Post date:** [January 18, 2022, 10:43pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/51 "2022-01-18T22:43:27Z")

</div>

> [@Horatius](#):
>
> Nuedexta

DXM plus quinidine sulfate, two of the older, cheaper drugs on the planet, together in a high priced pill. Shades of Martin Shkreli!

---

<div class="post-metadata">

**Author:** ![Jackmannii](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/jackmannii/32/311_2.png) [@Jackmannii](https://boards.straightdope.com/u/Jackmannii)\
**Post date:** [January 18, 2022, 11:00pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/52 "2022-01-18T23:00:46Z")

</div>

> [@SpacemanSpiff\_II](#):
>
> Do any of your examples involve drugs which were off patent at the time they were repurposed for other use? AFAICT, you’re talking about drugs which were in development form at the time of the repurposing or at least under patent at the time. This has nothing at all to do with the situation we’re discussing.

How about thalidomide? It was not only off patent, but nobody wanted to touch it with a ten-foot pole owing to its sinister history of causing fetal malformations.

Then somebody looked into its potential for treating other diseases (such as leprosy and multiple myeloma) and it wound up as a highly profitable drug for Celgene, reportedly earning the company $7 billion in one recent year (Celgene was accused of using the tight regulatory restrictions governing its marketing of the drug as an excuse to maintain its patent and block generic versions). There are also derivatives of thalidomide now in use and presumably patented.

Apparently there are complex regulatory hoops to jump through before off-patent drugs can be repurposed for treating other ailments, and drug companies have been reluctant to invest in research including expensive large phase III clinical trials. But as the Celgene example shows, if you get a winner there’s a lot of money to be made.

---

<div class="post-metadata">

**Author:** ![Northern\_Piper](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/northern_piper/32/5304_2.png) [@Northern\_Piper](https://boards.straightdope.com/u/Northern_Piper)\
**Post date:** [January 19, 2022, 3:20am UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/53 "2022-01-19T03:20:22Z")

</div>

> [@gdave](#):
>
> I don’t think that played much of a role. It’s my understanding that those studies didn’t come out until after ivermectin had already become established as a “real” treatment. Here’s my (layman’s) understanding:

Fascinating. Thank you.

---

<div class="post-metadata">

**Author:** ![SpacemanSpiff\_II](https://avatars.discourse-cdn.com/v4/letter/s/e19adc/32.png) [@SpacemanSpiff\_II](https://boards.straightdope.com/u/SpacemanSpiff_II)\
**Post date:** [January 19, 2022, 3:16pm UTC](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674/54 "2022-01-19T15:16:12Z")

</div>

> [@Jackmannii](#):
>
> How about thalidomide? It was not only off patent, but nobody wanted to touch it with a ten-foot pole owing to its sinister history of causing fetal malformations.
> 
> Then somebody looked into its potential for treating other diseases (such as leprosy and multiple myeloma) and it wound up as a highly profitable drug for Celgene, reportedly earning the company $7 billion in one recent year (Celgene was accused of using the tight regulatory restrictions governing its marketing of the drug as an excuse to maintain its patent and block generic versions). There are also derivatives of thalidomide now in use and presumably patented.

I believe it was off patent but was banned from use altogether, so as a practical matter generic versions were not available. That’s effectively the same as a patent, for purposes of this discussion.

> [@Jackmannii](#):
>
> Apparently there are complex regulatory hoops to jump through before off-patent drugs can be repurposed for treating other ailments, and drug companies have been reluctant to invest in research including expensive large phase III clinical trials.

But here’s the thing. I’m not discussing patenting repurposed drugs as a standalone topic. The question in this thread is “_What do the people who think ivermectin is effective against COVID-19 believe is the reason health providers do not want to prescribe it?_” I pointed out that one rational basis for discounting the reluctance of health providers is because there are economic disincentives to proving the effectiveness for new uses of drugs which are available in generic form. You’re now saying that “_there are complex regulatory hoops to jump through before off-patent drugs can be repurposed for treating other ailments, and drug companies have been reluctant to invest in research including expensive large phase III clinical trials_”. So it sounds like you agree with me. A guy who says “_I think ivermectin probably works and the reason doctors are reluctant to provide it is because it hasn’t gained acceptance, which is in turn because there are complex regulatory hoops to jump through before off-patent drugs can be repurposed for treating other ailments, and drug companies have been reluctant to invest in research including expensive large phase III clinical trials_” would be saying something that you agree is not unreasonable?

[Note again, that this is **not** the same thing as saying that it’s likely that ivermectin is actually effective for covid. But that’s not the question which was raised in this thread.]

[Previous page](https://boards.straightdope.com/t/what-do-the-people-who-think-ivermectin-is-effective-against-covid-19-believe-is-the-reason-health-providers-do-not-want-to-prescribe-it/957674.md?page=2)
